共 50 条
- [45] Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis Advances in Therapy, 2020, 37 : 2956 - 2975
- [46] Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis ADVANCES IN THERAPY, 2020, 37 (06) : 2956 - 2975
- [47] Effects of inhaled corticosteroids/long-acting beta-2 agonist fix combinations in COPD TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2011, 59 (01): : 89 - 100
- [48] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
- [49] The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management PRIMARY CARE RESPIRATORY JOURNAL, 2010, 19 (02): : 93 - 103